150 related articles for article (PubMed ID: 23108631)
1. Safety and immunogenicity of recombinant human thrombin: a pooled analysis of results from 10 clinical trials.
Singla NK; Foster KN; Alexander WA; Pribble JP
Pharmacotherapy; 2012 Nov; 32(11):998-1005. PubMed ID: 23108631
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin.
Ballard JL; Weaver FA; Singla NK; Chapman WC; Alexander WA
J Am Coll Surg; 2010 Feb; 210(2):199-204. PubMed ID: 20113940
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of re-exposure to recombinant human thrombin in surgical hemostasis.
Singla NK; Gasparis AP; Ballard JL; Baron JM; Butine MD; Pribble JP; Alexander WA;
J Am Coll Surg; 2011 Dec; 213(6):722-7. PubMed ID: 21958507
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human thrombin: safety and immunogenicity in pediatric burn wound excision.
Foster KN; Mullins RF; Greenhalgh DG; Gamelli RL; Glat P; Lentz CW; Kahn SA; Brandigi C; Fredlund P; Alexander WA
J Pediatr Surg; 2011 Oct; 46(10):1992-9. PubMed ID: 22008340
[TBL] [Abstract][Full Text] [Related]
5. A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures.
Weaver FA; Lew W; Granke K; Yonehiro L; Delange B; Alexander WA;
J Vasc Surg; 2008 Jun; 47(6):1266-73. PubMed ID: 18440754
[TBL] [Abstract][Full Text] [Related]
6. Recombinant thrombin: safety and immunogenicity in burn wound excision and grafting.
Greenhalgh DG; Gamelli RL; Collins J; Sood R; Mozingo DW; Gray TE; Alexander WA
J Burn Care Res; 2009; 30(3):371-9. PubMed ID: 19349898
[TBL] [Abstract][Full Text] [Related]
7. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis.
Singla NK; Ballard JL; Moneta G; Randleman CD; Renkens KL; Alexander WA
J Am Coll Surg; 2009 Jul; 209(1):68-74. PubMed ID: 19651065
[TBL] [Abstract][Full Text] [Related]
8. A review of three stand-alone topical thrombins for surgical hemostasis.
Cheng CM; Meyer-Massetti C; Kayser SR
Clin Ther; 2009 Jan; 31(1):32-41. PubMed ID: 19243705
[TBL] [Abstract][Full Text] [Related]
9. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
Ofosu FA; Crean S; Reynolds MW
Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142
[TBL] [Abstract][Full Text] [Related]
10. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis.
Chapman WC; Singla N; Genyk Y; McNeil JW; Renkens KL; Reynolds TC; Murphy A; Weaver FA
J Am Coll Surg; 2007 Aug; 205(2):256-65. PubMed ID: 17660072
[TBL] [Abstract][Full Text] [Related]
11. Topical recombinant human thrombin in surgical hemostasis.
Bowman LJ; Anderson CD; Chapman WC
Semin Thromb Hemost; 2010 Jul; 36(5):477-84. PubMed ID: 20632245
[TBL] [Abstract][Full Text] [Related]
12. Bovine thrombin: history, use, and risk in the surgical patient.
Diesen DL; Lawson JH
Vascular; 2008; 16 Suppl 1():S29-36. PubMed ID: 18544303
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human thrombin: in surgical hemostasis.
Croxtall JD; Scott LJ
BioDrugs; 2009; 23(5):333-8. PubMed ID: 19754221
[TBL] [Abstract][Full Text] [Related]
14. Topical thrombins: benefits and risks.
Lomax C; Traub O
Pharmacotherapy; 2009 Jul; 29(7 Pt 2):8S-12S. PubMed ID: 19558279
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of a dry-powder, fibrin sealant in vascular procedures.
Gupta N; Chetter I; Hayes P; O-Yurvati AH; Moneta GL; Shenoy S; Pribble JP; Zuckerman LA
J Vasc Surg; 2015 Nov; 62(5):1288-95. PubMed ID: 26254451
[TBL] [Abstract][Full Text] [Related]
16. Topical recombinant thrombin at a concentration of 1000 IU/mL reliably shortens in vivo TTH and delivers durable hemostasis in the presence of heparin anticoagulation and clopidogrel platelet inhibition in a rabbit model of vascular bleeding.
Hughes SD; Bishop PD; Garcia R; Zhang T; Alexander WA
Ann Surg Innov Res; 2009 Nov; 3():14. PubMed ID: 19925675
[TBL] [Abstract][Full Text] [Related]
17. Acquired factor V inhibitor after exposure to topical human thrombin related to an otorhinolaryngological procedure.
Donohoe K; Levine R
J Thromb Haemost; 2015 Oct; 13(10):1787-9. PubMed ID: 26270511
[TBL] [Abstract][Full Text] [Related]
18. Immune-mediated coagulopathy associated with topical bovine thrombin: review of the pediatric literature.
Rodgers GM
J Pediatr Hematol Oncol; 2011 Mar; 33(2):86-8. PubMed ID: 21228719
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of a novel, dry powder fibrin sealant for hemostasis in hepatic resection.
Ruitenbeek K; Ayez N; Verhoef C; de Wilt JH; Bottema J; Rijken AM; van Rij M; Koopman J; Zuckerman LA; Frohna P; Porte RJ
Dig Surg; 2014; 31(6):422-7. PubMed ID: 25592001
[TBL] [Abstract][Full Text] [Related]
20. Topical bovine thrombin and adverse events: a review of the literature.
Clark J; Crean S; Reynolds MW
Curr Med Res Opin; 2008 Jul; 24(7):2071-87. PubMed ID: 18549663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
